Page 50 - Read Online
P. 50

Page 12 of 13            Cangemi et al. Mini-invasive Surg 2022;6:3  https://dx.doi.org/10.20517/2574-1225.2021.99

                   PubMed
               46.      Ben-Dor I, Maluenda G, Looser PM, et al. Outcomes of concomitant percutaneous coronary intervention and balloon aortic
                   valvuloplasty. Catheter Cardiovasc Interv 2013;82:E835-41.  DOI  PubMed
               47.      Daniec M, Sorysz D, Dziewierz A, et al. In-hospital and long-term outcomes of percutaneous balloon aortic valvuloplasty with
                   concomitant percutaneous coronary intervention in patients with severe aortic stenosis. J Interv Cardiol 2018;31:60-7.  DOI  PubMed
               48.      Singh V, Mendirichaga R, Inglessis-Azuaje I, Palacios IF, O'Neill WW. The role of impella for hemodynamic support in patients with
                   aortic stenosis. Curr Treat Options Cardiovasc Med 2018;20:44.  DOI  PubMed
               49.      Diaz Quintero L, Gajo E, Guerrero M, Feldman T, Levisay J. Balloon aortic valvuloplasty followed by impella®-assisted left main
                   coronary artery percutaneous coronary intervention in patients with severe aortic stenosis as a bridge to transcatheter aortic valve
                   replacement. Cardiovasc Revasc Med 2021;22:16-21.  DOI  PubMed
               50.      Nai Fovino L, Scotti A, Massussi M, et al. Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
                   Catheter Cardiovasc Interv 2020;96:E535-41.  DOI  PubMed
               51.      Yudi MB, Sharma SK, Tang GHL, Kini A. Coronary angiography and percutaneous coronary intervention after transcatheter aortic
                   valve replacement. J Am Coll Cardiol 2018;71:1360-78.  DOI  PubMed
               52.      Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following
                   transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol 2013;62:1552-62.  DOI  PubMed
               53.      Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study. JACC
                   Cardiovasc Interv 2020;13:2542-55.  DOI  PubMed
               54.      Ochiai T, Chakravarty T, Yoon SH, et al. Coronary access after TAVR. JACC Cardiovasc Interv 2020;13:693-705.  DOI  PubMed
               55.      Katsanos S, Debonnaire P, van der Kley F, et al. Position of edwards SAPIEN transcatheter valve in the aortic root in relation with the
                   coronary ostia: implications for percutaneous coronary interventions. Catheter Cardiovasc Interv 2015;85:480-7.  DOI  PubMed
               56.      Abdelghani M, Landt M, Traboulsi H, Becker B, Richardt G. Coronary access after TAVR with a self-expanding bioprosthesis:
                   insights from computed tomography. JACC Cardiovasc Interv 2020;13:709-22.  DOI  PubMed
               57.      Rogers T, Greenspun BC, Weissman G, et al. Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients.
                   JACC Cardiovasc Interv 2020;13:726-35.  DOI  PubMed
               58.      Tang GHL, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve
                   orientation and coronary artery overlap. JACC Cardiovasc Interv 2020;13:1030-42.  DOI  PubMed
               59.      Tagliari AP, Vicentini L, Zimmermann JM, et al. Transcatheter aortic valve neo-commissure alignment with the Portico system.
                   EuroIntervention 2021;17:e152-5.  DOI  PubMed
               60.      Bieliauskas G, Wong I, Bajoras V, et al. Patient-specific implantation technique to obtain neo-commissural alignment with self-
                   expanding transcatheter aortic valves. JACC Cardiovasc Interv 2021;14:2097-108.  DOI  PubMed
               61.      Tarantini G, Nai Fovino L, Le Prince P, et al. Coronary access and percutaneous coronary intervention up to 3 years after transcatheter
                   aortic valve implantation with a balloon-expandable valve. Circ Cardiovasc Interv 2020;13:e008972.  DOI  PubMed  PMC
               62.      Khan M, Senguttuvan NB, Krishnamoorthy P, et al. Coronary angiography and percutaneous coronary intervention after transcatheter
                   aortic valve replacement with medtronic self-expanding prosthesis: insights from correlations with computer tomography. Int J Cardiol
                   2020;317:18-24.  DOI  PubMed
               63.      Bharadwaj AS, Bhatheja S, Sharma SK, Kini AS. Utility of the guideliner catheter for percutaneous coronary interventions in patients
                   with prior transcatheter aortic valve replacement. Catheter Cardiovasc Interv 2018;91:271-6.  DOI  PubMed
               64.      Ochiai T, Yoon SH, Flint N, et al. Timing and outcomes of percutaneous coronary intervention in patients who underwent
                   transcatheter aortic valve implantation. Am J Cardiol 2020;125:1361-8.  DOI  PubMed
               65.      Stefanini GG, Cerrato E, Pivato CA, et al; REVIVAL Investigators. Unplanned percutaneous coronary revascularization after TAVR: a
                   multicenter international registry. JACC Cardiovasc Interv 2021;14:198-207.  DOI  PubMed
               66.      Faroux L, Lhermusier T, Vincent F, et al. ST-segment elevation myocardial infarction following transcatheter aortic valve
                   replacement. J Am Coll Cardiol 2021;77:2187-99.  DOI  PubMed
               67.      Kim WK, Pellegrini C, Ludwig S, et al. Feasibility of coronary access in patients with acute coronary syndrome and previous TAVR.
                   JACC Cardiovasc Interv 2021;14:1578-90.  DOI  PubMed
               68.      Nai Fovino L, Scotti A, Massussi M, et al. Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the
                   risk of coronary access impairment after TAVR-in-TAVR. J Am Heart Assoc 2020;9:e016446.  DOI  PubMed  PMC
               69.      Baumbach H, Schairer ER, Wachter K, et al. Transcatheter aortic valve replacement- management of patients with significant coronary
                   artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures. BMC
                   Cardiovasc Disord 2019;19:108.  DOI  PubMed  PMC
               70.      Ahad S, Wachter K, Rustenbach C, et al. Concomitant therapy: off-pump coronary revascularization and transcatheter aortic valve
                   implantation. Interact Cardiovasc Thorac Surg 2017;25:12-7.  DOI  PubMed
               71.      Mayr B, Firschke C, Erlebach M, et al. Transcatheter aortic valve implantation and off-pump coronary artery bypass surgery: an
                   effective hybrid procedure in selected patients. Interact Cardiovasc Thorac Surg 2018;27:102-7.  DOI  PubMed
               72.      Pirelli L, Patel NC, Scheinerman JS, et al. Hybrid minimally invasive approach for combined obstructive coronary artery disease and
                   severe aortic stenosis. Innovations (Phila) 2020;15:131-7.  DOI  PubMed
               73.      Santana O, Funk M, Zamora C, Escolar E, Lamas GA, Lamelas J. Staged percutaneous coronary intervention and minimally invasive
                   valve surgery: results of a hybrid approach to concomitant coronary and valvular disease. J Thorac Cardiovasc Surg 2012;144:634-9.
                   DOI  PubMed
               74.      Santana O, Xydas S, Williams RF, et al. Outcomes of a hybrid approach of percutaneous coronary intervention followed by minimally
   45   46   47   48   49   50   51   52   53   54   55